メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
富山大学 ホーム
日本語
English
ホーム
プロファイル
研究部門
プロジェクト
研究成果
データセット
受賞
活動
コース
専門知識、名前、または所属機関で検索
朝日・地域医療支援学講座
富山大学
附属病院
概要
フィンガープリント
ネットワーク
プロファイル
(1)
プロジェクト
(1)
研究成果
(50)
フィンガープリント
朝日・地域医療支援学講座が活動している研究トピックを掘り下げます。これらのトピックラベルは、この組織のメンバーの研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Keyphrases
Lung Cancer
100%
Non-small Cell Lung Cancer (NSCLC)
52%
Japan
51%
Sirtuin 1 (SIRT1)
41%
Prognostic Factors
34%
Monotherapy
33%
Afatinib
31%
C-Jun N-terminal Kinase Signaling
31%
SRT1720
31%
Small Cell Lung Cancer
31%
Elderly Patients
31%
Point-of-care Ultrasound (POCUS)
31%
Progression-free Survival
29%
Lung Adenocarcinoma
28%
Body Mass Index
24%
Ultrasound Examination
23%
Thickening Fraction
23%
MRNA Level
23%
Asthma
22%
Clinical Course
22%
Dyspnea
22%
Lactate Dehydrogenase
21%
EGFR-mutant Lung Cancer
21%
Older Men
21%
Young Patients
20%
Performance Status
19%
Adverse Effects
19%
Appetite Loss
19%
Ischemic Heart Disease
18%
Training Course
18%
Trauma
18%
EGFR Status
17%
Leptomeningeal Carcinomatosis
17%
Gefitinib
17%
Physical Activity
16%
Lung
16%
General Medicine
16%
Mouse Model of Asthma
15%
Total Adiponectin
15%
Multiple Mini-interview
15%
Medical Admissions
15%
Maintenance Treatment
15%
Regulated on Activation
15%
Hepatitis C Virus Antibodies
15%
Job Description
15%
Large-scale Observational Study
15%
Bioelectrical Impedance Analysis
15%
Novice Learners
15%
Chronic Obstructive Pulmonary Disease Patient
15%
PD-1 Inhibitor
15%
Esophageal Hematoma
15%
Pulmonary Hamartoma
15%
Non-squamous Cell Lung Cancer
15%
Urine Cortisol
15%
Inhibitor Therapy
15%
Phase II Study
15%
Non-small Cell Lung Cancer Cells
15%
Local Therapy
15%
Rapid Response System
15%
Triage Tool
15%
National Early Warning Score
15%
Previously Untreated
15%
Pulmonary Sarcomatoid Carcinoma
15%
Malignant Mesothelioma
15%
Hospitalized Patients
15%
Cartilage Fracture
15%
Common Cause
15%
Local Community
15%
Tissue Level
15%
Non-squamous
15%
Impaired Lung Function
15%
Alveolar Epithelial Cells
15%
Systemic Therapy
15%
Right Lower Lobe
15%
Palliative Prognostic Index
15%
Pneumocystis Jirovecii
15%
Comorbidity
15%
Third-line Chemotherapy
15%
Postoperative Recurrence
15%
Nasogastric Tube
15%
Pulmonary Function
15%
MRNA Expression
15%
Visceral Adipose Tissue
15%
Ovalbumin
15%
Lung Cancer Cell Lines
15%
Multidrug Resistance Protein
15%
Isoproterenol
15%
Squamous Cell
15%
Acute Hepatitis C
15%
Lung Injury
15%
Cancer Study
15%
Pemetrexed
15%
Forkhead Box O1 (FOXO1)
15%
Clinical Parameters
15%
Systemic Dissemination
15%
Chronic Pulmonary Aspergillosis
15%
Doxorubicin
15%
Krebs Von Den Lungen-6 (KL-6)
15%
Hepatotoxicity
15%
Parkinson's Disease
15%
Medicine and Dentistry
Lung Cancer
94%
Retrospective Study
42%
Small Cell Lung Cancer
36%
Non Small Cell Lung Cancer
31%
Sirtuin1
31%
Point-of-Care Ultrasound
31%
Lung Adenocarcinoma
28%
Epidermal Growth Factor Receptor
25%
Dyspnea
24%
Diaphragm
23%
Disease
23%
Disease Course
22%
Adverse Event
21%
Lung
21%
Body Mass Index
20%
Amino Terminal Sequence
19%
Loss of Appetite
19%
Outpatient
18%
Tumor Cell
18%
Injury
18%
Monotherapy
17%
Messenger RNA
17%
Cross Sectional Study
17%
Gefitinib
17%
Meningeal Carcinomatosis
17%
Physical Activity
16%
Local Therapy
15%
Hamartoma
15%
Acute Hepatitis C
15%
Multidrug Resistance Associated Protein 1
15%
Pneumocystis Pneumonia
15%
Systemic Therapy
15%
Lung Cancer Cell Line
15%
Recurrent Disease
15%
Doxorubicin
15%
Phosphotransferase
15%
Hydrocortisone
15%
Cartilage Fracture
15%
Hepatitis C Virus
15%
Amrubicin
15%
Mesothelioma
15%
Sarcomatoid Carcinoma
15%
Lung Aspergillosis
15%
Chronic Obstructive Pulmonary Disease
15%
Afatinib
15%
Parkinson's Disease
15%
Hematoma
15%
Triage
15%
Rapid Response Team
15%
Peripheral Blood Mononuclear Cell
15%
Esophagus
15%
SRT1720
15%
Anisakiasis
15%
Liver Toxicity
15%
Erlotinib
15%
Cricoid Cartilage
15%
Wheeze
15%
Ischemic Heart Disease
15%
Prognostic Factor
15%
Retrospective Cohort Study
15%
Radiation Pneumonia
15%
Elderly Patient
15%
Breast Cancer
15%
Lung Metastasis
15%
Lactate Dehydrogenase
15%
Cell Migration
15%
Acupuncture
15%
Comorbidity
15%
Chemotherapy
15%
Metastatic Carcinoma
15%
Fibrosis
13%
Cancer Cell
12%
Deterioration
12%
Cisplatin
11%
Virus Antibody
11%
Computer Assisted Tomography
10%
Skeletal Muscle
10%
Progression Free Survival
10%
Multivariate Analysis
10%
Minoxidil
9%
Asthma
9%
Hyperpnea
8%
Sarcopenia
8%
Tongue
7%
Surgery
7%
Swallowing
7%
Hospitalist
7%
Skill Retention
7%
Nurse Practitioner
7%
Lumbar Puncture
7%
Chylous Ascites
7%
Thoracic Wall
7%
Overall Survival
7%
Muscle Tone
7%
Brain Metastasis
7%
Quality of Life
7%
Muscle Rigidity
7%
Chest Radiograph
7%
Hyperthyroidism
7%
Congestive Heart Failure
7%
Pharmacology, Toxicology and Pharmaceutical Science
Epidermal Growth Factor Receptor
53%
Non Small Cell Lung Cancer
50%
Small Cell Lung Cancer
47%
Retrospective Study
43%
Lung Cancer
43%
Progression Free Survival
35%
Messenger RNA
34%
Phosphotransferase
31%
N [2 [3 (1 piperazinylmethyl)imidazo[2,1 B]thiazol 6 Yl]phenyl] 2 Quinoxalinecarboxamide
31%
Chemotherapy
28%
Monotherapy
28%
Asthma
27%
Adverse Event
26%
Lactate Dehydrogenase
23%
Inflammation
19%
Cytokine
18%
Neoplasm
17%
Squamous Cell Lung Carcinoma
15%
Afatinib
15%
Disease Course
15%
Acute Hepatitis C
15%
Multidrug Resistance Associated Protein 1
15%
Isoprenaline
15%
Doxorubicin
15%
Chronic Obstructive Lung Disease
15%
Recurrent Disease
15%
Mouse Model
15%
Ovalbumin
15%
Wheezing
15%
Hepatitis C Virus
15%
Sirtuin 1
15%
Protein P53
15%
Ionizing Radiation
15%
Cohort Study
15%
Group Trial
15%
Loss of Appetite
15%
Hydrocortisone
15%
Pemetrexed
15%
Radiation Pneumonia
15%
Deterioration
15%
Amrubicin
15%
Ischemic Heart Disease
15%
Lung Metastasis
15%
Breast Cancer
15%
Phosphatase
15%
Disease
15%
Overall Survival
13%
Fibrosis
13%
Docetaxel
12%
Minoxidil
11%
Cisplatin
11%
Virus Antibody
11%
Observational Study
9%
Parkinson's Disease
7%
Muscle Rigidity
7%
Chylous Ascites
7%
Diarrhea
7%
Hyperthyroidism
7%
Congestive Heart Failure
7%
Hepatitis C
6%
anthra[1,9 Cd]pyrazol 6(2h) One
6%
Disease Exacerbation
6%
Aspartate Aminotransferase
5%
Alanine Aminotransferase
5%
Rash
5%
Respiratory Tract Inflammation
5%
C Reactive Protein
5%
Receptor Antagonist
5%
Phosphotransferase Inhibitor
5%